Key result
Pulmonary artery pressure ≥35 mmHg linked to ~19% higher recurrence risk after AF ablation.
Why the study?
It remained to be determined whether pulmonary artery pressure is associated with AF recurrence after radiofrequency catheter ablation.
Does elevated baseline pulmonary artery pressure (≥35 mmHg) increase the risk of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with atrial fibrillation?
Cohort (n=2,379)
No
Does elevated baseline pulmonary artery pressure (≥35 mmHg) increase the risk of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with atrial fibrillation?
Elevated baseline pulmonary artery pressure (≥35 mmHg) is an independent predictor of atrial arrhythmia recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
Elevated PAP may aid post-ablation risk stratification in AF; leaves open whether pulmonary pressure modification improves outcomes.
Background The pulmonary veins play a major role in the pathogenesis of atrial fibrillation (AF) and may be affected by cardiac remodeling due to pulmonary vascular dysfunction. It remains to be determined whether pulmonary artery pressure (PAP) is associated with the recurrence of AF after radiofrequency catheter ablation (RFCA). Methods Consecutive patients with paroxysmal and persistent AF who underwent RFCA, including wide circumferential pulmonary vein isolation, were analyzed. Systolic PAP was measured using transthoracic echocardiography, and clinical outcomes were compared between patients with PAP <35 mmHg and those with PAP ≥35 mmHg. Results Among 2,379 patients (mean age 56.7 ± 10.6 years, 77% men), 1,893 (79.6%) had PAP <35 mmHg and 486 (20.4%) had PAP ≥35 mmHg. During the median follow-up of 25.4 months, in patients with paroxysmal AF ( n = 1,294), the recurrence rate was significantly greater in the PAP ≥35 mmHg group than in the PAP <35 mmHg group (35.1% vs. 23.8%, log-rank p = 0.008). However, in patients with persistent AF ( n = 1,085), the recurrence rate was not significantly different between the two groups (52.2% vs. 49.7%, log-rank p = 0.409). Multivariate analysis using Cox regression showed that PAP ≥35 mmHg was significantly associated with clinical recurrence (hazard ratio 1.19, 95% confidence interval 1.02–1.40, p = 0.027). Conclusion This study showed that a higher PAP was associated with an increased risk of recurrence after RFCA in patients with paroxysmal AF, suggesting a mechanism by which a pulmonary vascular pathology may cause impairment of the pulmonary veins and remodeling of the left atrium.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2023) conducted a cohort in Atrial fibrillation (n=2,379). Pulmonary artery pressure ≥35 mmHg vs. Pulmonary artery pressure <35 mmHg was evaluated on Clinical recurrence of atrial arrhythmia after radiofrequency catheter ablation (HR 1.19, 95% CI 1.02-1.40, p=0.027). Pulmonary artery pressure ≥35 mmHg was independently associated with an increased risk of clinical recurrence after radiofrequency catheter ablation in patients with atrial fibrillation (HR 1.19).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: